Such results are in line with findings from cancer immunotherapies in which PD-1 blockade results in increased Treg suppression [14], which needs further verification as some studies reported opposite results that PD-1 blockade could help overcome Treg suppression [15]. The gene discussed is PDCD1; the disease is cancer.